← Evidence map

ArticleFrontiers in medicine2026

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series.

Giulia Odorici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42523870